tiprankstipranks
Trending News
More News >
Aethlon (AEMD)
:AEMD
US Market

Aethlon Medical (AEMD) Stock Forecast & Price Target

Compare
543 Followers
See the Price Targets and Ratings of:

AEMD Financial Forecast

AEMD Earnings Forecast

Next quarter’s earnings estimate for AEMD is -$1.07 with a range of -$1.20 to -$0.98. The previous quarter’s EPS was -$1.04. AEMD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year AEMD has Outperformed its overall industry.
Next quarter’s earnings estimate for AEMD is -$1.07 with a range of -$1.20 to -$0.98. The previous quarter’s EPS was -$1.04. AEMD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year AEMD has Outperformed its overall industry.

AEMD Sales Forecast

Next quarter’s sales forecast for AEMD is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. AEMD beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year AEMD has Preformed in-line its overall industry.
Next quarter’s sales forecast for AEMD is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. AEMD beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year AEMD has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on AEMD
Vernon BernardinoH.C. Wainwright
H.C. Wainwright
$7
Buy
297.73%
Upside
Reiterated
03/10/25
Buy Rating for Aethlon Medical Driven by Hemopurifier's Potential in Organ Transplantation and Projected GrowthOur $7 PT was derived by using a weighted-average cost of capital (WACC) of 11% for Aethlon Medical shares to discount free cash flows we project for F2025 through F2035, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then ascribing a 0% terminal growth rate and 25% probability of success.
Maxim Group Analyst forecast on AEMD
Anthony VendettiMaxim Group
Maxim Group
Hold
Reiterated
02/13/25
Aethlon Medical (AEMD) Receives a Hold from Maxim Groupwe maintain our Hold rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on AEMD
Vernon BernardinoH.C. Wainwright
H.C. Wainwright
$7
Buy
297.73%
Upside
Reiterated
03/10/25
Buy Rating for Aethlon Medical Driven by Hemopurifier's Potential in Organ Transplantation and Projected GrowthOur $7 PT was derived by using a weighted-average cost of capital (WACC) of 11% for Aethlon Medical shares to discount free cash flows we project for F2025 through F2035, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then ascribing a 0% terminal growth rate and 25% probability of success.
Maxim Group Analyst forecast on AEMD
Anthony VendettiMaxim Group
Maxim Group
Hold
Reiterated
02/13/25
Aethlon Medical (AEMD) Receives a Hold from Maxim Groupwe maintain our Hold rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Aethlon Medical

1 Month
xxx
Success Rate
4/12 ratings generated profit
33%
Average Return
-4.20%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -4.20% per trade.
3 Months
xxx
Success Rate
3/12 ratings generated profit
25%
Average Return
-21.12%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -21.12% per trade.
1 Year
Vernon BernardinoH.C. Wainwright
Success Rate
0/12 ratings generated profit
0%
Average Return
-64.31%
reiterated a buy rating 3 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -64.31% per trade.
2 Years
xxx
Success Rate
0/12 ratings generated profit
0%
Average Return
-78.76%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -78.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AEMD Analyst Recommendation Trends

Rating
Aug 24
Nov 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
1
1
1
1
Buy
1
0
1
2
2
Hold
2
3
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
4
5
4
In the current month, AEMD has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AEMD average Analyst price target in the past 3 months is 7.00.
Each month's total comprises the sum of three months' worth of ratings.

AEMD Stock Forecast FAQ

What is AEMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Aethlon’s 12-month average price target is 7.00.
    What is AEMD’s upside potential, based on the analysts’ average price target?
    Aethlon has 297.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AEMD a Buy, Sell or Hold?
          Aethlon has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Aethlon’s price target?
            The average price target for Aethlon is 7.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $7.00 ,the lowest forecast is $7.00. The average price target represents 297.73% Increase from the current price of $1.76.
              What do analysts say about Aethlon?
              Aethlon’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of AEMD?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis